Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Nature Medicine

• Publication date

  2014-01-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nm.3443PMID 24412922PMCID PMC3966466
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human IgG Fc domain engineering enhances antitoxin neutralizing antibody activity.

  2014cited by this paper
• Identification of Dominant Antibody-Dependent Cell-Mediated Cytotoxicity Epitopes on the Hemagglutinin Antigen of Pandemic H1N1 Influenza Virus

  2013cited by this paper
• Peptide-Conjugation Induced Conformational Changes in Human IgG1 Observed by Optimized Negative-Staining and Individual-Particle Electron Tomography

  2013cited by this paper
• Cetuximab-mediated tumor regression depends on innate and adaptive immune responses.

  2013cited by this paper
• Cross-Reactive Influenza-Specific Antibody-Dependent Cellular Cytotoxicity Antibodies in the Absence of Neutralizing Antibodies

  2013cited by this paper
• Antibody-Dependent Cellular Cytotoxicity Is Associated with Control of Pandemic H1N1 Influenza Virus Infection of Macaques

  2013cited by this paper
• Mouse model recapitulating human Fcγ receptor structural and functional diversity

  2012cited by this paper
• Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells

  2012cited by this paper
• Universal vaccine against influenza virus: Linking TLR signaling to anti‐viral protection

  2012cited by this paper
• A Pan-H1 Anti-Hemagglutinin Monoclonal Antibody with Potent Broad-Spectrum Efficacy In Vivo

  2012cited by this paper
• Highly Conserved Protective Epitopes on Influenza B Viruses

  2012cited by this paper
• A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins

  2011cited by this paper
• Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

  2011cited by this paper
• Anti-tumor activity and toxicokinetics analysis of MGAH22, an anti-HER2 monoclonal antibody with enhanced Fcγ receptor binding properties

  2011cited by this paper
• Inhibitory Fcγ Receptor Engagement Drives Adjuvant and Anti-Tumor Activities of Agonistic CD40 Antibodies

  2011cited by this paper
• Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection

  2011cited by this paper
• Catching a Moving Target

  2011cited by this paper
• The ferret as a model organism to study influenza A virus infection

  2011cited by this paper
• FcγRs in health and disease.

  2011cited by this paper
• Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection

  2011cited by this paper
• FcγRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo

  2010cited by this paper
• Protection of Mice against Lethal Challenge with 2009 H1N1 Influenza A Virus by 1918-Like and Classical Swine H1N1 Based Vaccines

  2010cited by this paper
• A requirement for FcγR in antibody-mediated bacterial toxin neutralization

  2010cited by this paper
• Broadly Protective Monoclonal Antibodies against H3 Influenza Viruses following Sequential Immunization with Different Hemagglutinins

  2010cited by this paper
• Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

  2009cited by this paper
• Antibody Recognition of a Highly Conserved Influenza Virus Epitope

  2009cited by this paper
• Neutralizing Anti-Influenza Virus Monoclonal Antibodies: Therapeutics and Tools for Discovery

  2009cited by this paper
• Analyzing antibody-Fc-receptor interactions.

  2008cited by this paper
• Fcγ receptors as regulators of immune responses

  2008cited by this paper
• Fcgamma receptors as regulators of immune responses.

  2008cited by this paper
• Antibodies, Fc receptors and cancer.

  2007cited by this paper
• Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic

  2007cited by this paper
• The Immunoglobulin Heavy Chain Constant Region Affects Kinetic and Thermodynamic Parameters of Antibody Variable Region Interactions with Antigen*

  2007cited by this paper
• Fcγ receptor-dependent effector mechanisms regulate CD19 and CD20 antibody immunotherapies for B lymphocyte malignancies and autoimmunity

  2006cited by this paper
• FcγRIV : A novel FcR with distinct IgG subclass specificity

  2005cited by this paper
• FcgammaRIV: a novel FcR with distinct IgG subclass specificity.

  2005cited by this paper
• Divergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding

  2005cited by this paper
• Influenza A Vaccine Based on the Extracellular Domain of M2: Weak Protection Mediated via Antibody-Dependent NK Cell Activity

  2004cited by this paper
• CD107a as a functional marker for the identification of natural killer cell activity.

  2004cited by this paper
• Evidence of allosteric conformational changes in the antibody constant region upon antigen binding.

  2003cited by this paper
• An antibody that prevents the hemagglutinin low pH fusogenic transition.

  2002cited by this paper
• FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection.

  2002cited by this paper
• Mechanism of neutralization of influenza virus infectivity by antibodies.

  2002cited by this paper
• Fc Receptor-Mediated Phagocytosis Makes a Significant Contribution to Clearance of Influenza Virus Infections1

  2001cited by this paper
• Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.

  2000cited by this paper
• Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets

  2000cited by this paper
• Augmented humoral and anaphylactic responses in FcγRII-deficient mice

  1996cited by this paper
• Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice.

  1996cited by this paper
• Impaired IgG-Dependent Anaphylaxis and Arthus Reaction in FcγRIII (CD16) Deficient Mice

  1996cited by this paper
• Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice.

  1996cited by this paper
• FcR γ chain deletion results in pleiotrophic effector cell defects

  1994cited by this paper
• FcR gamma chain deletion results in pleiotrophic effector cell defects.

  1994cited by this paper
• Non-covalent interactions between Fab and Fc regions in immunoglobulin G molecules. Hydrogen-deuterium exchange studies.

  1987cited by this paper
• Characterization of monoclonal antibodies specific for sequential influenza A/PR/8/34 virus variants.

  1986cited by this paper
• Immunity to influenza in man.

  1983cited by this paper
• Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation

  1981cited by this paper
• Induction of an Fc conformational change by binding of antigen: the generation of protein A-reactive sites in chicken immunoglobulin.

  1979cited by this paper
• Antigen-induced conformational changes in antibodies and their Fab fragments studied by circular polarization of fluorescence.

  1975cited by this paper

• Development of a potent monoclonal antibody for treatment of human metapneumovirus infections.

  2026cites this paper
• Decoding Protein Glycosylation for Better Vaccine and Antibody Development.

  2026cites this paper
• Cross-species cellular mapping and humanization of Fcγ receptors to advance antibody modeling.

  2026cites this paper
• How Broadly Neutralising Antibodies Are Redefining Immunity to Influenza

  2025cites this paper
• Protective activity of CR9114 universal antibody isotypes against influenza A virus in vivo

  2025cites this paper
• Soluble influenza H3 trimer proteins enhance the breadth and potency of antibody response.

  2025cites this paper
• Analysis of Fc-dependent effector functions of anti-malaria circumsporozoite protein antibodies

  2025cites this paper
• Omicron Variant Could Be an Antigenic Shift of SARS-CoV-2

  2025cites this paper
• Cross-Reactive Fc-Mediated Antibody Responses to Influenza HA Stem Region in Human Sera Following Seasonal Vaccination

  2025cites this paper
• Mucosal immunity elicited by a human-Fcγ receptor-I targeted intranasal vaccine platform enhances resistance against nasopharyngeal colonization of Streptococcus pneumoniae and induces broadly protective immunity against respiratory pathogens.

  2025cites this paper
• FLU-v, a Broad-Spectrum Peptide-Based Influenza Vaccine, Induces NK Cell Activating IgG1 and IgG3 Subclass Antibodies in Humans

  2025cites this paper
• Polyclonal and Monoclonal Antibodies for the Treatment and Prevention of Influenza.

  2025cites this paper
• A broadly neutralizing antibody confers cross-genus protection against alphaherpesviruses by inhibiting gB-mediated membrane fusion

  2025cites this paper
• Spike-specific IgG4 generated post BNT162b2 mRNA vaccination is inhibitory when directly competing with functional IgG subclasses

  2025cites this paper
• Induction of hemagglutinin stalk reactive antibodies by the administration of a live-attenuated influenza virus vaccine in children

  2025cites this paper
• A monoclonal anti-hemagglutinin stem antibody modified with zanamivir protects against both influenza A and B viruses

  2025cites this paper
• FcγRIIIa is a noncanonical costimulatory molecule for CD8 T cells

  2025cites this paper
• A protective and broadly binding antibody class engages the influenza virus hemagglutinin head at its stem interface

  2025cites this paper
• Broad Mucosal and Systemic Immunity in Mice Induced by Intranasal Booster With a Novel Recombinant Adenoviral Based Vaccine Protects Against Divergent Influenza A Virus

  2025cites this paper
• Pre-exposure antibody prophylaxis protects macaques from severe influenza.

  2025cites this paper
• Administration of antigenically distinct influenza viral particle combinations as an influenza vaccine strategy

  2025influential citation
• DNA vaccines targeting hemagglutinin from 18 subtypes of influenza A virus to antigen-presenting cells confer broad protection

  2025cites this paper
• Long-lasting B cell convergence to distinct broadly reactive epitopes following vaccination with chimeric influenza virus hemagglutinins.

  2025cites this paper
• Improved cross-protection and immunity against influenza A virus in mice using a novel mRNA vaccine with optimized design of RNA sequence

  2025cites this paper
• T and B cell responses in different immunization scenarios for COVID-19: a narrative review

  2025cites this paper
• Integrative multi-omics analysis in vivo identifies influenza virus host factors

  2025cites this paper
• CD47 inhibits phagocytosis through Vav dephosphorylation.

  2025cites this paper
• Intranasal Vaccine Induces Broad and Long-Lasting Immunity Against the Hemagglutinin Stem of Group 2 Influenza A Viruses.

  2025cites this paper
• Increased Chemokine Production is a Hallmark of Rhesus Macaque Natural Killer Cells Mediating Robust Anti-HIV Envelope-Specific Antibody-Dependent Cell-Mediated Cytotoxicity

  2025cites this paper
• CD47 prevents Rac-mediated phagocytosis through Vav1 dephosphorylation

  2025cites this paper
• Applications and insights from continuous dengue virus infection in a stable cell line

  2025cites this paper
• The mechanistic basis for interprotomer deglycosylation of antibodies by corynebacterial IgG-specific endoglycosidases

  2025cites this paper
• SMALL MOLECULES WHICH CAN KEEP THE ECTODOMAINS OF HUMAN FcγRIIIa “CLOSED”: THERAPY FOR AUTOIMMUNE THROMBOCYTOPENIA PURPURA?

  2025cites this paper
• Cytotoxic IgG: Mechanisms, functions, and applications.

  2025cites this paper
• Structure and function of a cross-neutralizing influenza neuraminidase antibody that accommodates recent N2 NA Asn245 glycosylation

  2025cites this paper
• Non-neutralizing antibodies to influenza A matrix-protein-2-ectodomain are broadly effective therapeutics and resistant to viral escape mutations

  2025cites this paper
• Single-domain antibodies directed against hemagglutinin and neuraminidase protect against influenza B viruses

  2025cites this paper
• Mature Dendritic Cell-Derived Extracellular Vesicles are Potent Mucosal Adjuvants for Influenza Hemagglutinin Vaccines

  2025cites this paper
• More antibodies are not always better: Fc effector functions play a critical role in SARS-CoV-2 infection and protection.

  2025cites this paper
• Molecular parameters governing antibody FcγR signaling and effector functions in the context of HIV envelope.

  2025cites this paper
• Intranasal administration of a panreactive influenza antibody reveals Fc-independent mode of protection

  2025cites this paper
• Antibody function predicts viral control in newborn monkeys immunised with an influenza virus HA stem nanoparticle

  2025cites this paper
• Childhood immunological imprinting of cross-subtype antibodies targeting the hemagglutinin head domain of influenza viruses

  2025cites this paper
• Structure and function of a cross-neutralizing influenza neuraminidase antibody that accommodates recent N2 NA Asn245 glycosylation

  2025cites this paper
• Decreased Fc fucosylation aligns with enhanced RSV-specific antibody functionality in adults compared to young children

  2025cites this paper
• In vivo efficacy of combined human broadly neutralizing antibodies against hepatitis B virus.

  2025cites this paper
• Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens.

  2025cites this paper
• Modulation of T-Cell-Dependent Humoral Immune Response to Influenza Vaccine by Multiple Antioxidant/Immunomodulatory Micronutrient Supplementation

  2024cites this paper
• Identification and verification of key molecules in the epileptogenic process of focal cortical dysplasia

  2024cites this paper
• A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoprotein

  2024cites this paper
• Human neutralizing antibodies target a conserved lateral patch on H7N9 hemagglutinin head

  2024cites this paper
• Are we serologically prepared against an avian influenza pandemic and could seasonal flu vaccines help us?

  2024cites this paper
• B cells secrete functional antigen-specific IgG antibodies on extracellular vesicles

  2024cites this paper
• Linking Antibodies Against Apolipoprotein A-1 to Metabolic Dysfunction-Associated Steatohepatitis in Mice

  2024cites this paper
• Antigen spatial-matching polyaptamer nanostructure to block coronavirus infection and alleviate inflammation

  2024cites this paper
• Site‐specific serology unveils cross‐reactive monoclonal antibodies targeting influenza A hemagglutinin epitopes

  2024cites this paper
• Fc‐FcγR interactions during infections: From neutralizing antibodies to antibody‐dependent enhancement

  2024cites this paper
• Fc-dependent protective efficacy of non-inhibitory antibodies targeting influenza A virus neuraminidase is limited by epitope availability

  2024cites this paper
• Disulfide-stabilized trimeric hemagglutinin ectodomains provide enhanced heterologous influenza protection

  2024cites this paper
• Protective Non-neutralizing anti-N-terminal Domain mAb Maintains Fc-mediated Function against SARS-COV-2 Variants up to BA.2.86-JN.1 with Superfluous In Vivo Protection against JN.1 Due to Attenuated Virulence.

  2024cites this paper
• Antibody‐mediated control mechanisms of viral infections

  2024cites this paper
• Antigen specificity shapes antibody functions in tuberculosis

  2024cites this paper
• Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response

  2024cites this paper
• Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge

  2024cites this paper
• The function of antibodies

  2024cites this paper
• Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine

  2024cites this paper
• An inactivated whole-virion vaccine for Enterovirus D68 adjuvanted with CpG ODN or AddaVax elicits potent protective immunity in mice.

  2024cites this paper
• Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge

  2024cites this paper
• Vaccination with antigenically complex hemagglutinin mixtures confers broad protection from influenza disease

  2024cites this paper
• Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins

  2024cites this paper
• Therapeutic efficacy of a potent anti-Venezuelan equine encephalitis virus antibody is contingent on Fc effector function

  2024cites this paper
• Broadly Reactive Nanobody Targeting the H3 Hemagglutinin of the Influenza A Virus

  2024cites this paper
• The lipid globotriaosylceramide promotes germinal center B cell responses and antiviral immunity

  2024cites this paper
• Headless hemagglutinin-containing influenza viral particles direct immune responses toward more conserved epitopes

  2024cites this paper
• SARS-CoV-2 spike-reactive naïve B cells and pre-existing memory B cells contribute to antibody responses in unexposed individuals after vaccination

  2024cites this paper
• Site-Specific Glycosylation Analysis of Murine and Human Fcγ Receptors Reveals High Heterogeneity at Conserved N-Glycosylation Site

  2024cites this paper
• Immunogenicity of chimeric hemagglutinins delivered by an orf virus vector platform against swine influenza virus

  2024cites this paper
• Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium

  2024cites this paper
• Hemagglutinin stalk-specific Fc-mediated functions are associated with protection against influenza-illness after seasonal influenza vaccination in pregnant women.

  2024cites this paper
• Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice

  2023cites this paper
• Protective efficacy of a universal influenza mRNA vaccine against the challenge of H1 and H5 influenza A viruses in mice

  2023cites this paper
• Protective non-neutralizing mAbs targets conserved opsonic epitopes on SARS-CoV-2 variants

  2023cites this paper
• The lipid Gb3 promotes germinal center B cell responses and anti-viral immunity

  2023cites this paper
• Antibody-mediated NK cell activation as a correlate of immunity against influenza infection

  2023cites this paper
• Use of Biolayer Interferometry to Identify Dominant Binding Epitopes of Influenza Hemagglutinin Protein of A(H1N1)pdm09 in the Antibody Response to 2010–2011 Influenza Seasonal Vaccine

  2023cites this paper
• Vaccine-induced neutralizing antibody responses to seasonal influenza virus H1N1 strains are not enhanced during subsequent pandemic H1N1 infection

  2023cites this paper
• Influenza H3 hemagglutinin vaccine with scrambled immunodominant epitopes elicits antibodies directed toward immunosubdominant head epitopes

  2023cites this paper
• Human anti-N1 monoclonal antibodies elicited by pandemic H1N1 virus infection broadly inhibit HxN1 viruses in vitro and in vivo.

  2023cites this paper
• An mRNA-based broad-spectrum vaccine candidate confers cross-protection against heterosubtypic influenza A viruses

  2023cites this paper
• Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations

  2023cites this paper
• Combined anti-S1 and anti-S2 antibodies from hybrid immunity elicit potent cross-variant ADCC against SARS-CoV-2

  2023cites this paper
• A fully human monoclonal antibody possesses antibody‐dependent cellular cytotoxicity (ADCC) activity against the H1 subtype of influenza A virus by targeting a conserved epitope at the HA1 protomer interface

  2023cites this paper
• Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza

  2023influential citation
• Nanoparticles Carrying Conserved Regions of Influenza A Hemagglutinin, Nucleoprotein, and M2 Protein Elicit a Strong Humoral and T Cell Immune Response and Protect Animals from Infection

  2023cites this paper
• Construction of an inhalable recombinant M2e-FP-expressing Bacillus subtilis spores-based vaccine and evaluation of its protection efficacy against influenza in a mouse model.

  2023cites this paper
• A pan-influenza antibody inhibiting neuraminidase via receptor mimicry

  2023cites this paper
• Fc-Effector-Independent in vivo Activity of a Potent Influenza B Neuraminidase Broadly Neutralizing Antibody

  2023cites this paper
• Pilot-scale production of inactivated monoglycosylated split H1N1 influenza virus vaccine provides cross-strain protection against influenza viruses.

  2023cites this paper
• Post-fusion influenza vaccine adjuvanted with SA-2 confers heterologous protection via Th1-polarized, non-neutralizing antibody responses.

  2023cites this paper
• Prolonging the delivery of influenza virus vaccine improves the quantity and quality of the induced immune responses in mice

  2023cites this paper